Protective Effects of Piroxicam Against Anthracene-Induced Haematological and Biochemical Alteration in Female Rats
References
- 1. Lindsey, P. A., Nyirenda, V. R., Barnes, J. I., Becker, M. S., McRobb, R., Tambling, C. J., et al., 2014: Underperformance of African protected area networks and the case for new conservation models: insights from Zambia. Plos One, 9, 5, e94109. DOI: 10.1371/journal.pone.0094109
- 2. IARC, 2004: Tobacco smoke and involuntary smoking. Monographs on the Evaluation of Carcinogenic Risk to Humans, 83, 33–1187.
- 3. Collin, G., H ö ke, H., Talbiersky, J., 2006: Anthracene. In Ullmann ’ s Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim. DOI: 10.1002/14356007.a02_343. pub2
- 4. Verschueren, K., Marcoen, A., Schoefs, V., 1996: The internal working model of the self, attachment, and competence in five-year-olds. Child Dev., 67, 5, 2493–2511.DOI: 10.2307/1131636
- 5. Rao, P-S. 2014: Anthracene. In Encyclopaedia of Toxicology, 3rd ed., pp. 260–261.
- 6. Abdul Lateef, E. N., Hussein, M. A., Mustafa, S. R., Taen, M. M., Ali, S. A., Saheab, N., 2021: Toxicity of anthracene on the function of the liver and kidney of the common carp cypricus carpio. Egyptian J. Aquat. Biol. Fish, 25, 3, 3, 831–840. DOI: 10.21608/EJABF.2021.182302
- 7. Dey, S., Samanta, P., Mondal, N. S., Kole, D., Mandal, A., Patra, A., Ghosh, A. R., 2019: Dose specific responses of Anabas testudineus (Bloch) to anthracene (PAH): haemato-logical and biochemical manifestation. Emerg. Contamin., 5, 232–239. DOI: 10.1016/j.emcon.2019.07.001
- 8. Palanikumar, L., Kumaraguru, A. K., Ramakritinan, C. M., Anand, M., 2012: Biochemical response of anthracene and benzo[a]pyrene to milkfish Chanos chanos. Ecotoxicol. Environ. Saf., 75, 1, 187–197. DOI: 10.1016/j. ecoenv.2011.08.028
- 9. Saganuwan, S. A., Orinya, O. A. 2016: Toxico-neurological effects of piroxicam in monogastric animals. J. Exp. Neurosci., 10, 121–128. DOI: 10.4137/JEn.s40144
- 10. Saganuwan, S. A., Onyeyili, P. A., 2016: The paradox of human equivalent dose formula: a canonical case study of Abrus precatorius aqueous leaf extract in monogastric animals. Mac. Vet. Rev., 39, 1, 23–32. DOI: 10.1515/macvetrev-2015-0061
- 11. Akogwu, E. I., Saganuwan, S. A., Onyeyili, P. A., 2017: Comparative pharmacokinetics of piroxicam in male and female west African dwarf goats. Cog. Food Agric., 3, 1–8. DO I: 10.1080/23311932.2017.1294444
- 12. Oluchi, O. M., Chukwuebuka, N. H., Orbunde, D. K., Daniel, W. A., Aondohemba, U.V., Ieren, I. I., et al., 2024: Evaluation of Benz[a]anthracene-induced pulmonary toxicity in Rattus norvegicus. J. Toxicity Envir. Health Sci., 16, 1, 1–12. DOI: 10.5897/JTEHS2023.0517
- 13. Thermo Fisher Scientific, 2024: Carboplatin In: Safety Data Sheet, Health, Safety and Environment Department. pp. 1–8.
- 14. Saganuwan, S. A., 2019: Effects of therapeutic and toxic agents on erythrocytes of different species of animals. In Erythrocytes, Intech Open, London, pp. 176. DOI: 10.5772/intechopen.85865
- 15. Uzoamaka, A. M., Saganuwan, S. A., Ahur, M. V., Akande, T. 2025: Ameliorative effects of piroxicam on anthracene-induced lung toxicity in female Rattus norvegicus. Folia Vet., 69, 4, 49–63. DOI: 10.2478/fv-2025-0036
- 16. Saganuwan, S. A., 2012: Principle of pharmacological calculations 1st ed; Ahmadu Bello University press, pp. 528.
- 17. Kisani, A. I., Immaculate, A. N., Saganuwan, S. A., 2022: Comparative local anaesthetic effect of lignocaine, ligno-caine-adrenaline and water extracts of Annona muricata during castration in dogs. Adv. Trad. Med. 23, 851–861. DOI: 10.1007/s13596-022-00655-1
- 18. Saganuwan, S. A., Onyeyili, P. A., 2012: Haematonic and plasma expander effects of aqueous leaf extract of Abrus precalorius in Mus musculus. Comp. Clin. Pathol., 21, 1249–1255. DOI: 10.1007/s00580-011-1274-8
- 19. Brown, B. A., 1976: Haematology principles and procedures, 2nd ed. Lea and Fabiger, Philadelphia, pp. 56–81.
- 20. Cheesebrough, M., 2005: Examination of blood for malaria parasite. District Laboratory practice in tropical countries. Part 1. Cambridge University Press, Cambridge, pp. 434.
- 21. Talke, H., Schubert, G. E., 1965: Enzymatic urea determination in the blood and serum in the Warburg optical test. Klin. Wohcenschr., 43, 174–175.
- 22. Blass, K. G., Thibert, R. J., Lam, L. K., 1974: A study of mechanism of Jaff é reaction. Clin. Chem., 12, 7, 336–343. DOI: 10.1515/cclm.1974.12.7.336
- 23. Saganuwan, S. A., 2018: The use of body surface area for determination of age, body weight, urine creatinine, plasma creatinine, serum creatinine, urine volume and creatinine clearance: the reliable canonical method for accessing renotoxicity in animals. Comp. Clin. Pathol., 27, 1531–1536. DOI: 10.1007/s00580-018-2769-3
- 24. Bergemeyer, H. U., Bowers Jr., G. N., Horder, M., Moss, D. W., 1976: Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2. IFCC method for aspartate aminotransferase. Clin. Chim. Acta, 70, 2, 19–29. PMID: 954207
- 25. Henley, K. S., 1980: IFCC method for alanine aminotransferase. Clin. Chim. Acta, 105, 1, 155–166. DOI: 10.1016/0009-8981(80)90106-0
- 26. Roy, A. V., 1970: Rapid method for determining alkaline phosphatase activity in serum with thymolphthalein mono-phosphate. Clin. Chem., 16, 5, 431–436. PMID: 5443769
- 27. Williams, A. L. B. and Hoofnagle, J. H., 1988: Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis relationship to cirrhosis. Gastroenterol., 95, 3, 734–739. DOI: 10.1016/s0016-5085(88)80022-2
- 28. Daniel, W. W., 2010: Biostatistics: Basic Concept and Methodology for Health Sciences, 9th ed., Wiley, New Delhi, pp. 783.
- 29. Zahorec, R., 2021: Neutrophil to lymphocyte ratio, past, present and future perspectives. Bratisl. Med. J., 122, 7, 474–488. DOI: 10.4149/BLL_2021_078
- 30. Cohen, J. A., Kaplan, M. M., 1979: The SGOT/SGPT ratio–an indicator of alcoholic liver disease. Dig. Dis. Sci., 24, 11, 835–838. DOI: 10.1007/BF01324898
- 31. Saganuwan, S. A., 2023: Ameliorative effects of piroxicam on perchloric acid-induced thyroid gland hormones disruption in male rats. J. King Saud Univ-Sci., 35, 5, 102661. DOI: 10.1016/j.jksus.2023.102661
- 32. Roeland, E. J., Fintelmann, F. J., Hilton, F., Yang, R., Whalen, E., Tarasenko, L., et al., 2024: The relationship between weight gain during chemotherapy and outcomes in patients with advanced non-small cell lung cancer. J. Cachexia Sarcopenia Muscle, 15, 3, 1030–1040. DOI: 10.1002/jcsm.13426
- 33. Story, A. L., Boston, S. E., Kilkenny, J. J., Singh, A., Woods, J. P., Culp, W. T. N., et al., 2017: Evaluation of weight change during carboplatin therapy in dogs with appendicular osteosarcoma. J. Vet. Intern. Med., 31, 4, 1159–1162. DOI: 10.1111/jvim.14724
- 34. Cheng, Y.-J., Wu, R., Cheng, M.-L., Du, J., Hu, X.-W., Yu, L., et al., 2017: Carboplatin-induced hematotoxicity among patients with non-small cell lung cancer: Analysis on clinical adverse events and drug-gene interactions. Oncotarget, 8, 19, 32228–32236. DOI: 10.18632/oncotarget.12951
- 35. Kasuga, I., Makino, S., Kiyokawa, H., Katoh, H., Ebihara, Y., Ohyashiki, K., 2001: Tumor-related leukocytosis as linked with poor prognosis in patient with lung carcinoma. Cancer, 92, 9, 2399–2405. DOI: 10.1002/1097-0142(20011101)92:9<;2399::aid-cncr1588>3.0.co;2-w
- 36. Sprague, B. L., Trentham-Dietz, A., Klein, B. E. K., Klein, R., Cruickshanks, K. J., Lee, K. E., Hampton, J. M., 2008: Physical activity, white blood cell count, and lung cancer risk in a prospective cohort study. Cancer Epidemiol. Biomarkers Prev., 17, 10, 2714–2722. DOI: 10.1158/1055-9965.EPI-08-0042
- 37. Wong, J. Y. Y., Bassig, B. A., Loftfield, E., Hu, W., Freedman, N. D., Ji, B., et al., 2020: White blood cell count and risk of incident lung cancer in the UK Biobank. JNCI Cancer Spect., 4, 2, 1–9. DOI: 10.1093/jncics/pkz102
- 38. Uribe – Querol, E., Rosales, C., 2015: Neutrophils in cancer: two sides of the same coin. J. Immunol. Res., 1, 983698, 1–21. DOI: 10.1155/2015/983698
- 39. Kohutek, F., Bystricky, B., 2019: Leukocytosis as a negative prognostic factor in patients with lung cancer: Which subpopulation of leucocytes is responsible? Tumor Biol. Pathol., 30, 5, 799.
- 40. Saganuwan, S.A., 2016: Physicochemical and structure-activity properties of piroxicam—a mini review. Comp Clin Pathol., 25, 941–945. DOI: 10.1007/s00580-016-2284-3
- 41. Young, B., Stewart, W., O ’ Dowd, G., 2011: Wheater’s basic pathology: a text, atlas and review of histopathology. 15th ed. International edition. pp. 174–175.
- 42. Campbell, M.S., Makar, G.A., 2005: Safety of short-term administration of celecoxib in decompensated cirrhosis. Hepatol., 42, 1, 238. DOI: 10.1002/hep.20744
- 43. Aloe, C., Wang, H., Vlahos, R., Irving, L., Steinfort, D., Bozinovski, S., 2021: Emerging and multifaceted role of neutrophils in lung cancer. Transl. Lung Cancer Res., 10, 6, 2806–2818. DOI: 10.21037/tlcr-20-760
- 44. Wang, Z., Chen, B., Fu, Y., Ou, C., Rong, Q., Kong, X., et al., 2022: Eosinophilia and Lung Cancer: Analysis from Real-World Data and Mendelian Randomization Study. Front. Med. (Lausanne), 9, 830754. DOI: 10.3389/fmed.2022.830754
- 45. Anthony, H. M., 1982: Blood basophils in lung cancer. Br. J. Cancer, 45, 2, 209–216. DOI: 10.1038/bjc.1982.35
- 46. Ahur, V. M., Agada, P. O., Saganuwan, S. A., 2012: Estimating the plasma and serum activity levels of aspartate aminotransferase and alanine aminotransferase, in live animals using regression model. Trends Appl. Sci. Res., 7, 9, 748–757. DOI: 10.3923/tasr.2012.748.757
- 47. Saganuwan, S. A., 2017: Functional chemical groups that may likely become a source for the synthesis of novel central nervous system (cns) acting drugs. Centr. Nerv. Syst. Agents Med. Chem., 17, 3, 178–186. DOI: 10.2174/187152491766 6170502153752
- 48. Saganuwan, S. A., 2017: Toxicity studies of drugs and chemicals in animals: an overview. Bulg. J. Vet. Med., 20, 4, 291–318. DOI: 10.15547/bjvm.983
- 49. Saganuwan, S. A., 2019: Chemistry and effects of brainstem acting drugs. Centr. Nerv. Syst. Agents Med. Chem., 19, 3, 180–186. DOI: 10.2174/1871524919666190620164355
- 50. Sedlack, A. J. H., Meyer, C., Mench, A., Winters, C., Barbon, D., Obrzut, S., Mallak, N., 2024: Essentials of theranostics: A guide for physicians and medical physicists. Radiographics, 44, 1, e230097. DOI: 10.1148/rg.230097
- 51. Pradhan, S., Sonkar, C. K., 2023: Theranostic in nuclear medicine: Therapy to impact patient management and secure the future in the era of precision oncology. Oncol. Radiother. 17, 12, 756–763.
- 52. Awuah, W. A., Ahluwalia, A., Tan, J. K., Sanker, V., Roy, S., Ben-Jaafar, A., et al., 2025: Theranostics advances in the treatment and diagnosis of neurological and neurosurgical diseases. Arch. Med. Res., 56, 1, 103085. DOI: 10.1016/j. arcmed.2024.103085
- 53. Alexander, S. P. H., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., et al., 2023: The concise guide to pharmacology 2023/24: Introduction and other protein targets. Brit. J. Pharmacol., 180, S2, S1–S22. DOI: 10.1111/bph.16176
- 54. Ekhart, C., Rodenhuis, S., Schellens, J. H. M., Beijnen, J. H., Huitema, A. D. R., 2009: Carboplatin dosing in over-weight and obese patients with normal renal function, does weight matter? Cancer Chemother. Pharmacol. 64, 1, 115–122. DOI: 10.1007/s00280-008-0856-x
- 55. Saganuwan, S. A., 2017: In vivo piroxicam metabolites: Possible sources for synthesis of central nervous system acting depressants. Cent. Nerv. Syst. Agents Med. Chem., 17, 3, 172–177. DOI: 10.2174/1871524917666161111093759
- 56. Egbewale, S. O., Kumar, A., Mokoena, M. P., Olaniran, A. O., 2025: Optimization of anthracene biodegradation by indigenous Trichoderma lixii and Talaromyces pinophilus using response surface methodology. Ecotoxicol. Environ. Saf., 289, 117431. DOI: 10.1016/j.ecoenv.2024.117431
- 57. Schwenk, M. H., 2024: Carboplatin dosing on the basis of renal function: 30+ years after calvert. Kidney 360, 5, 2, 271–273. DOI: 10.34067/KID.0000000000000349
- 58. Chmielewski, P. P., Strzelec, B., Mozdziak, P., Kempisty, B., 2025: Neutrophil-to-lymphocyte ratio as a prognostic biomarker for long-term survival in older adults at a mental health care center: a historical cohort analysis. J. Clin. Med., 14, 7, 2509. DOI: 10.3390/jcm14072509
- 59. Xu, M., Yang, X., Zhang, J., Liu, D., Zhang, C., Wu, M., et al. 2024: The mechanism of anthracene degradation by trylophan-2,3-dioxygenase (T23D) in Comamonas testosteroni. Chem. Biol. Interact., 393, 110950. DOI: 10.1016/j. cbi.2024.110950
- 60. Omar, A. M., Abdulmalik, O., El-say, K.M., Ghatge, M. S., Cyril-Olutayo, M., Paredes, S., et al., 2023: Targeted modification of furan-2-carboxaldehydes into Michael acceptor analogs yielded long-acting hemoglobin modulators with dual antisickling activities. Chem. Biol. Drug Des., 103, 1, e14371. DOI: 10.1111/cbdd.14371
- 61. Diaz-Uribe, C., Vallejo, W., Quinones, C., 2020: Physical-chemical study of anthracene selective oxidation by a Fe(III)- phenylporphyrin derivative. Int. J. Mol. Sci., 21, 1, 353. DOI: 10.3390/ijms21010353
- 62. Saganuwan, S. A, 2024: Structure-activity relationship of pharmacophores and toxicophores: the need for clinical strategy. Daru J. Pharm. Sci., 32, 2, 781–800. DOI: 10.1007/s40199-024-00525-y
- 63. Saganuwan, S. A, 2021: Application of modified Michaelis-Menten equations for determination of enzyme inducing and inhibiting drugs. BMC Pharmacol. Toxicol., 22, 57, 1–15. DOI: 10.1186/s40360-021-00521-x
- 64. de Sousa, G. F., Wlodarczyk, S.R., Monteiro, G., 2014: Carboplatin: Molecular mechanisms of action associated with chemoresistance. Braz. J. Pharm. Sci., 50, 4. 10.1590/S1984-82502014000400004
- 65. Kaushal, A., Verma, P., Singh, A. P., Singh, A. P., 2024: A critical review of piroxicam: From mechanism to adverse effects in clinical use. IJIRT, 11, 6, 3807–3811.
- 66. Mazumder, M. K., Borah, A., 2014: Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug. Med. Hypotheses, 83, 6, 740–746. DOI: 10.1016/j.mehy.2014.09.031
- 67. Reitzer, L., 2004: Biosynthesis of glutamate, aspartate, asparagine, L-Alanine, and D-Alanine. EcoSal Plus, 1, 1, 26443364. DOI: 10.1128/ecosalplus.3.6.1.3
Language: English
Page range: 33 - 46
Submitted on: Jun 15, 2025
Accepted on: Dec 15, 2026
Published on: Mar 21, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Uzoamaka Maryjane Anthony, Saganuwan Alhaji Saganuwan, Victor Maskavem Ahur, Akande Titilayo, published by The University of Veterinary Medicine and Pharmacy in Košice
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.